Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / CS
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
175K
-
Shares change
-
+17.8K
-
Total reported value, excl. options
-
$3.98M
-
Value change
-
+$404K
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$22.74
Significant Holders of CHUGAI PHARMA UNSUP ADR - CS (CHGCY) as of Q1 2025
11 filings reported holding CHGCY - CHUGAI PHARMA UNSUP ADR - CS as of Q1 2025.
CHUGAI PHARMA UNSUP ADR - CS (CHGCY) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175K shares
.
Largest 10 shareholders include Sterling Capital Management LLC (72K shares), CONFLUENCE INVESTMENT MANAGEMENT LLC (38.9K shares), RHUMBLINE ADVISERS (27.4K shares), PNC Financial Services Group, Inc. (13.4K shares), RIVERBRIDGE PARTNERS LLC (10.9K shares), GAMMA Investing LLC (9.87K shares), Brooklyn Investment Group (1.51K shares), HANTZ FINANCIAL SERVICES, INC. (516 shares), Accent Capital Management, LLC (400 shares), and THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. (256 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.